Funded Tech Companies
Ucello Therapeutics
Researching who provided funding to Ucello Therapeutics? Matrix Partners, Elikon Venture and Northern Light Venture Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Ucello Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
D1 Tianfu International Biological City Shuangliu District
Chengdu, Undisclosed
China
Chengdu, Undisclosed
China
Phone
Website
Email Address
Company Background Information
Overview
Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/23/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Qiang Zou
Company Investors
- Matrix Partners (Eric Yu)
- Elikon Venture
- Northern Light Venture Capital
- Co-win Healthcare Fund
- Chengdu International Bio-Town Investment and Development
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs